Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
ID:
Password:
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

Agents/Distributors
 Regional Subscription Agents/Distributors
 
Current Topics in Biochemical Research   Volumes    Volume 5 
Abstract
Development of antithrombin-heparin covalent complexes
Leslie R. Berry, Anthony K. C. Chan
Pages: 121 - 131
Number of pages: 11
Current Topics in Biochemical Research
Volume 5 

Copyright © 2003 Research Trends. All rights reserved

ABSTRACT

Heparin has been used for more than fifty years for treatment of thromboembolism. However, there are significant limitations with the use of heparin including the inability of heparin to inhibit clot-bound thrombin and decreased efficacy in clinical situations where antithrombin concentration is reduced. Scientists have attempted to overcome these limitations by developing antithrombin-heparin covalent complexes with limited success. Recently, we developed a simple method to generate potent antithrombin-heparin covalent complexes, which can inhibit clot-bound thrombin. This product has been characterized for its functional and structural properties. Animal experiments have shown that covalent antithrombin-heparin is potentially useful both as a systemic anticoagulant and a surface coating

Buy this Article


 
search


E-Commerce
Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Login
Search Products
Browse in Alphabetical Order : Journals
Series/Books
Browse by Subject Classification : Journals
Series/Books

Miscellaneous
Ordering Information Ordering Information
Downloadable forms Downloadable Forms